TOTUOP
CARM

Trustees of The University of Pennsylvania’s Carisma Therapeutics CARM Stock Holding History

Trustees of The University of Pennsylvania’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.23M Hold
1,252,107
– – 4.36% 3
2024
Q2 		$1.9M Hold
1,252,107
– – 7.39% 3
2024
Q1 		$2.84M Hold
1,252,107
– – 6.53% 4
2023
Q4 		$3.67M Sell
1,252,107
-507,737
-29% -$1.51M 10.07% 2
2023
Q3 		$7.44M Sell
1,759,844
-422,968
-19% -$2.68M 21.29% 2
2023
Q2 		$19.1M Hold
2,182,812
– – 14.43% 4
2023
Q1 		$6.77M Buy
+2,182,812
New +$20.8M 6.61% 4

Other funds holding CARM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return

Trustees of The University of Pennsylvania's CARM Position: Q3 2024 in Review

Trustees of The University of Pennsylvania held its Carisma Therapeutics (CARM) position steady in Q3 2024 at 1,252,107 shares worth $1.23M. The position accounts for 4.36% of the portfolio, ranked #3.

Trustees of The University of Pennsylvania first reported a position in CARM in Q1 2023 and has held it in 7 quarters since. The position peaked at $19.1M in Q2 2023. 37 funds tracked by Wall St. Rank hold CARM as of Q3 2024.

  • Trustees of The University of Pennsylvania held 1,252,107 shares of Carisma Therapeutics worth $1.23M as of Q3 2024.
  • Trustees of The University of Pennsylvania left its Carisma Therapeutics share count unchanged in Q3 2024.
  • Carisma Therapeutics made up 4.36% of Trustees of The University of Pennsylvania's portfolio in Q3 2024, its #3 holding.
  • Trustees of The University of Pennsylvania first reported a position in Carisma Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • Trustees of The University of Pennsylvania's Carisma Therapeutics position peaked at $19.1M in Q2 2023.
  • 37 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q3 2024.

Based on Trustees of The University of Pennsylvania's 13F filing for Q3 2024, filed 14 Nov 2024.